Biochemical activities of the derivatives of dehydrodicaffeic acid dilactone.

Authors:
  • YKYoshiki Kumada
    Yoshiki Kumada
  • HNHiroshi Naganawa
    Hiroshi Naganawa
  • TTTomio Takeuchi
    Tomio Takeuchi
  • HUHamao Umezawa
    Hamao Umezawa
  • KYKatsuji Yamashita
    Katsuji Yamashita
  • KWKiyoshi Watanabe
    Kiyoshi Watanabe

Abstract
Activities of derivatives of dehydrodicaffeic acid dilactone (DDCAD) to inhibit catechol-O-methyltransferase (COMT), cyclic AMP phosphodiesterase (PDE) and DOPA decarboxylase (DDC) were examined. Among those tested, 2,6-bis-(5',6'-dibromo-4'-hydroxy-3'-methoxyphenyl)-3,7-dioxabicyclo-[3,3,0]-octane 4,8-dione was found to be the strongest inhibitor of both COMT and PDE. There were no derivatives which showed a stronger inhibition against DDC than the original compound, DDCAD.